Lorillard
Topical Report NCI / S&Hp / Ornl Number 41 Site Visit I to Battelle Pacific Northwest Laboratories Rat Model Inhalatio N Bioassay Richland, Washington, 770223 - 770224
Fields
- Author
- Gill, B.E.
- Jenkins, R.A.
- Type
- SCRT, SCIENTIFIC REPORT
- CHAR, CHART/GRAPH/MAPS
- TRIP, TRIP REPORT
- Alias
- 89737683/89737698
- Area
- SPEARS,ALEXANDER/EXEC CONF ROOM STO
- Site
- G65
- Master ID
- 89737566/7894
- 89737566-7894 Annual Report Collection, Separation, and Elucidation of the Components of Cigarette Smoke and Cigarette Smoke Condensate Part I. Chemical Characterization of Experimental Cigarette Smokes Part II. Inhalation Bioassay Monitoring and Support Part III. Dosimetry and Bioimpact
- 89737577-7588 I. Chemical Characterization of Tobacco Smoke From Beagle Dog Inhalation Exposure Systems
- 89737589 II. Final Data - Series IV Cigarette Smoke and Condensate Chemical Analyses
- 89737590-7599 Topical Report NCI / S&Hp / Ornl Number 52 Final Smoke and Condensate Data for the Fourth Series of Experimental Varia Nts
- 89737600-7602 III. Chemical Analysis of Smokes of Foreign and Domestic Commercial Cigarettes
- 89737603-7606 Topical Report NCI / S&Hp / Ornl Number 49 Tar, Nicotine, Co and Co2 Deliveries of Philippine Cigarettes
- 89737607-7610 Topical Report NCI / S&Hp / Ornl Number 61 Tar, Nicotine, Co and Co2 Deliveries of Philippine Cigarettes
- 89737611-7614 Topical Report NCI / S&Hp / Ornl Number 66 Tar, Nicotine, Co and Co2 Deliveries of Italian Cigarettes
- 89737615-7621 Topical Report NCI / S&Hp / Ornl Number 51-A Chemical Analysis of Smoke From Second Set of Certain Domestic Commercial Low Tar and Nicotine Cigarettes
- 89737622-7624 Topical Report NCI / S&Hp / Ornl Number 53 Chemical Analysis of Smoke From Second Set of Certain Domestic Commercial Low Tar and Nicotine Cigarettes
- 89737625-7632 Topical Report NCI / S&Hp / Ornl Number 68 Chemical Analysis of Smoke From Selected South Florida Variants
- 89737633-7647 Topical Report NCI / S&Hp / Ornl Number 70 Chemical Analyses of Smoke From Selected Foreign Cigarettes United Kingdom, Uk Export, and Developing Nations
- 89737648-7649 IV. Swri Baboon Study Smoking Extremes Experiment
- 89737650-7655 Topical Report NCI / S&Hp / Ornl Number 58 Chemical Analysis of Smoke Delivered by Swri Baboon Study Cigarette Under Three Smoking Conditions
- 89737656-7661 V. Statistical Modeling of Histopathological Probabilities
- 89737669-7682 I. Monitoring of the Chronic Inhalation Exposures
- 89737699-7714 Topical Report NCI / S&Hp / Ornl Number 44 Site Visit Vi to Veteran's Administration Hospital East Orange, New Jersey, 770502 - 770503
- 89737715-7729 Topical Report NCI / S&Hp / Ornl Number 46 Site Visit IV to Hazleton Laboratory Reston, Virginia, 770521 - 770522
- 89737730-7748 Topical Report NCI / S&Hp / Ornl Number 48 Site Visit I to Enviro Control Inc. Inhalation Laboratories Temple Hills, M Aryland, 770523 - 770525
- 89737749-7760 Topical Report NCI / S&Hp / Ornl Number 54 Site Visit Vii to Veteran's Administration Hospital East Orange, New Jersey, 770808 - 770809
- 89737761-7768 Topical Report NCI / S&Hp / Ornl Number 55 Intercomparison of Tobacco Smoke Dose Beagle Dog Inhalation Bioassays
- 89737769-7777 Topical Report NCI / S&Hp / Ornl Number 59 Inhalation Bioassay of Tobacco Smoke in Pigeons Site Visit I to Beth Israel Hospital (Bih) Boston Massachusetts, 771130 - 771201
- 89737778-7798 Topical Report NCI / S&Hp / Ornl Number 60 Site Visit II to Battelle Pacific Northwest Laboratories Rat Model Inhalati on Bioassay Richland, Washington, 770914 - 770915
- 89737799-7817 Topical Report NCI / S&Hp / Ornl Number 62 Site Visit II to Borriston Research Laboratories Temple Hills, Maryland, 77 1107 - 771109
- 89737818-7833 Topical Report NCI / S&Hp / Ornl Number 64 Site Visit V to Hazleton Laboratories Reston, Virginia, 771105 - 771106
- 89737834-7844 Topical Report NCI / S&Hp / Ornl Number 67 Site Visit I to the Hazleton Laboratories Cofactor Inhalation Bioassay Rest on, Virginia, 780223
- 89737845-7856 II. Instrumental Approaches to Bioassay Monitoring
- 89737857-7858 III. Trapping and Determination of Organic Gas Phase Constituents of Cigarette Smoke
- 89737859-7862 Trapping and Determination of Labile Compounds in the Gas Phase of Cigarette Smoke
- 89737863-7865 IV. Determination of Nitric Oxide and Nitrogen Dioxide in Cigarette Smoke by Chemiluminescent Analysis
- 89737868-7869 I. Brl - Ornl Collaborative Smoke Particulate Deposition Experiment
- 89737870-7876 II. C Tracer Studies to Develop Sampling Protocols for Quantitative Nicotine Dosimetry Following Smoke Exposure
- 89737877-7884 III. Isolation and Quantitative Analysis of Nicotine and Cotinine in Physiological Fluids
- 89737885-7894 IV. Physiological Fluids Studies: Mutagenicity and Profiling
Related Documents:
Document Images
Topical Report
NCI/S&HP/ORNL #41
SITE VISIT I TO BATTELLE PACIFIC NORTHWEST LABORATORIES
RAT MODEL INHALATION BIOASSAY
Richland, Washington, February 23-24, 1977
5-27-77
R. A. Jenkins and B. E. Gill
Tobacco Smoke Research Program
Bio/Organic Analysis Section
Analytical Chemistry Division
Oak Ridge National Laboratory
Oak Ridge, Tennessee 37830
Interagency Agreement (ERDA-NIH/NCI) No. 40-485-74, Part II
Internal (ORNL) ContractCharge No. 3390-0224
Intended for informal communication with project management only.
Confidential until published or released by author.

Site Visit I to Battelle Pacific Northwest Laboratories
Rat Model Inhaltion Bioassay
R. A. Jenkins and B. E. Gill
Summar~y. Data gathered on the first visit to Battelle Pacific Northwest
Laboratories (BNW) to monitor the rat model inhalation bioassay suggest
that the smoke dose which the animals receive is similar in magnitude -
when normalized for body weight - to that which dogs in other NCI sponsored
inhalation bioassays are offered. The overall quality of the operation
and exposure procedure at BNW is very high. However, comparison of detailed
analyses of the on-site smokes with those generated analytically suggest
that significant changes in the chemical profile of the Code 27 variant may
occur under exposure conditions. This variant has also exhibited large
month-to-month variations in total particulate delivery.
Introduction. A first site visit was made to Battelle Pacific Northwest
Laboratories (BNW) on February 23-24, 1977. The primary purpose of the visit
was to °'shake down° monitoring procedures, identify future monitoring needs,
and discuss and observe the rat inhalation bioassay being conducted there.
Because of the helpful and cooperative attitude of the BNW staff, we were
able to obtain nearly 60 samples of smoke of the variants in use at the time
of the study. The purpose in obtaining these samples was to estimate the
amount of smoke being offered and retained by the animals, and to obtain some
measure of the chemical profile of the smoke being generated on-site and
offered the animals.
Experimental. Details of the exposure protocol can be found in the BNW Annual
Progress Report, "Inhalation Bioassay of Cigarette Smoke in Rats, January 1-
December 31, 1976." Briefly, eighty (80) animals per variant began full dose
exposure in May, 1976. Each animal is exposed to her share (ten animals per
chamber) of the smoke from eight cigarettes per day, spaced fairly evenly
over the course of 12 hours, seven days per week. Animals smoking the Code 27
variant are exposed to extra puffs, as that particular variant has a lower
average number of puffs.
To collect smoke particulates generated by the experimental variant, a
Cambridge filter pad is installed between the cigarette and the exposure
Cl~
GD
~
chamber. Grab samples of smoke inside the exposure chamber are taken by
.~
~
(b
~

withdrawing a 20-m1 sample immediately following introduction of smoke into the
chamber (at 3 seconds into the one minute exposure cycle), and immediately
prior to the flushing of the smoke from the chamber (at 27 seconds into the
exposure cycle). The 3 second sample is designed to provide a measure of
the amount of smoke available to the animal for inhalation. The 27-second
sample measures the amount of smoke remaining in the chamber. The smoke is
drawn through a small filter pad, and the nicotine present is taken as an in-
dicator of the amount of smoke sampled. Presumably, the difference in the
two samples is a measure of the amount of smoke actually inhaled and retained
by the animals. There are some difficulties associated with this method of
dose documentation, and these will be discussed later.
Smoke samples obtained at BNW were returned to ORNL for analysis. Nico-
tine is determined by extracting the filter pad with ethanol and analyzing an
aliquot of the extract by gas chromatography. Other analyses (referred to as
a multi-aliquot procedure and discussed later) are performed by extracting the
filter pad with pyridine, subjecting small aliquots to a tri-methyl silylating
procedure and analyzing these derivatived aliquots under varying gas chroma-
tographic conditions. The multi-aliquot procedure permits a much more detailed
chemical description of the smoke, as several components correlate highly
with the presence of entire classes of smoke constituents.
General Observations. The overall impression of the ORNL site visit team was
that the staff at RNW is doing a very good job of exposing the animals to a
reproducible amount of smoke, given the inherent limitations of the exposure
device and the animal model. While no cigarette static burn tests were made
on this visit (there was a problem with the balance used to weigh cigarettes -
see below), we noted that environmental conditions in the exposure wards were
as close to standard analytical smoking conditions (76°F, 60iu relative humidity)
as any we have observed in a chronic exposure situation. The temperature
in both exposure wards was recorded to be about 74°F, with a 65-72% relative
humidity. Ventilating air flow across the cigarettes was minimal, yet expo-
sure technicians commented that the fresh air supply was more than adequate
for comfort.
During our observation of the exposures, we noticed that there are a
sufficient number of technicians to handle the machines and animals. We
believe this to be an integral part of the overall quality of the 5NW exposure.

The technicians have sufficient time to actually observe the animals during
exposure, such that problems that arise during the smoking process receive
immediate attention. The animal containment tubes are kept clean. Careful
attention is paid to exposure protocols, such that animals smoking the Code
27 variant receive the proper number and type of extra puffs. Smoke exposure
machines are kept clean and in good working order. Communication between
the exposure technicians and the professional staff appears to be good.
Results and Discussion. Measurement of machine puffing parameters (frequency,
duration, volume) were not obtained on this visit. The Maddox-ORNL exposure
device does not have a fixed puffing volume. Rather, the pressure inside the
exposure chamber is decreased such that a 35 ml puff is drawn through the
cigarette placed at the front of the chamber. Of course, this net puff volume
can fluctuate with differences in resistance-to-draw of the cigarette or minor
leaks in the system. The protocol at BNW is to frequently recheck net puff
volume on a routine basis, to insure conformance to smoking standards.
During the visit, a problem developed with the analytical balance, such
that it would not weigh small masses (such as individual cigarettes) with
acceptable accuracy. Thus, contrary to our normal procedures, no weights for
cigarettes used in the on-site experiments were obtained. However, it has
been our experience that random cigarette selection yields averaqe weights
differing little from group averaged weights.
The total particulate matter (TPM) and nicotine values of the smoke
generated by the variants on the Maddox-ORNL machines at BNW are tabulated
in Table I. Table II lists the average values for each variant in comparison
with those from the same batch returned to ORNL and smoked under analytical
conditions. For the Code 32 and 27 variants, TPM and nicotine levels obtained
on the exposure devices are substantially above those obtained under analytical
conditions (Nicotine content of the Code 27 smoke is 65% greater than the
value obtained analytically). Values obtained analytically from the site visit
cigarettes are in good agreement with those obtained from the Tray Quality
Control cigarettes (See Topical Report x 40). Thus, smoking conditions in
the exposure wards at BNW probably contribute to an increased TPM and nicotine
delivery for the two variants (Code 13 values are elevated, but not so seriously
We would tend to rule out environmental factors (temperature, humidity, air
flow) because they are relatively close to standard analytical conditions.

Any alteration in the puffing performance of the exposure device to increase
the proportion of the total cigarette smoke which is collected (longer puff
duration, large puff volume) would be expected to be accompanied by a similar
reduction in the number of puffs. Such is not the case here. BNW has not
observed this phenornenen in their exposure ward tests. A conclusive answer
must await further on-site documentation.
As part of the monitoring protocol for the BNW bioassay, cigarettes are
sampled from those destined for use in the exposure and shipped to ORNL on a
monthly basis for analysis. This not only aids in better interlaboratory
comparison of bioassays, but also provides a measure of potential variation
in smoke dose to the animals resulting from fluctuations in cigarette smoke
delivery. Table III summarizes the results of these monthly analyses. The
Code 32 cigarettes show the least variation in delivery. For the months of
June and October, 1976, the Code 27 tar delivery was considerably below its
average value. The data here suggests that even for an inhalation bioassay
which is relatively well controlled, potential smoke dose variations due to
fluctuations in cigarette delivery may be expected.
Table IV summarizes chamber depletion data for the three variants as
measured on this visit. Nicotine values are expressed in terms of concen-
tration of nicotine (ug/ml) in the atmosphere available to the rats. Given
the inherent difficulties of measuring inhomogeneous concentrations of "live"
smoke, interpretation of chamber depletion measurements is by no means
straightforward. As the smoke remains in the chamber, it tends to plate out
on the chamber walls, reducing its effective concentration thorugh a non-
lung-deposition mechanism. In addition, nose seals are broken, exposing the
chamber contents to "fresh" air in the animal containment tubes, reducing
smoke concentration via dilution. Also, some smoke particulates condense on
the animals' fur. Presumably, chamber nicotine concentrations determined
from samples made only one second after the end of the puff (the 3-second
sample) should not have been affected by depletion through in-chamber conden-
sation, dilution, or lung deposition, and therefore should be a good measure
of the amount of smoke actually getting'into the chamber. Any loss of nicotine
presumably would be due to condensation of smoke particulates within the inlet
to the exposure chamber. Table V compares per cigarette deliveries of nicotine
calculated from the 3 second chamber grab samples and those determined by
GD

collecting the smoke as it leaves the butt of the cigarette. For the Code 27
and 32 variants, the data suggest that nearly half of the particulate phase
of the smoke condenses within the chamber inlet. Some inlet condensation of
smoke was observed, but we would estimate this amount to be much less than
50%. Since condensation and lung depositon of smoke are known to be time
dependent, the conclusion is that dilution of the smoke with "fresh" air from
the animal containment tubes must occur more rapidly than originally anti-
cipated. (Documentation of the actual amount of smoke drawn into the inhalation
chamber following completion of the puff - and thereby available for inhalation -
is important. We are presently developing a method by which the entire chamber
contents may be sampled for nicotine and carbon monoxide, and expect to initiate
such sampling on the next site visit.)
Despite the difficulties with the chamber depletion measurement, it is
still possible to estimate, using chamber depletion data, the amount of smoke
retained by the animal. Some preliminary dosimetry experiments in the ORNL
rat inhalation bioassay showed that about 76% of the smoke depleted from the
chamber - as measured by the chamber depletion method - deposited in the
respiratory tract of the animal. (This number may vary greatly for different
cigarette codes, depending on the "inhability" of the smoke.) Table VI com-
pares estimated weekly nicotine doses based on the chamber depletion data on
Table IV. (The Code 27 data has been adjusted for two additional puffs per
cigarette.) Interestingly, when body weights are normalized, rats smoking the
Code 32 variant at BNW receive about the same order of magnitude of smoke as
the Hazleton Laboratory dogs being exposed to the same variant (20 mg per
week per kg of body weight for the 200 g rats vs ,,14 mg for the 10 kg dogs).
One of the important functions of bioassay monitoring is to determine the
extent to which (if any) the smoke being offered the animals is an artifact
of the method of exposure (i.e., does the smoke being generated on-site differ
significantly in chemical composition from that generated under analytical
conditions). In an effort to more exactly define the chemical composition of
the particulate phase of the smoke being offered the animals, chamber input
samples were subjected to a multi-aliquot analysis procedure. Tables VII A-C
compare results obtained for the on-site samples with those obtained by
smoking cigarettes returned from BNW under analytical conditions. Comparison ~
~
C
1 J
M
aD
GID

is made between the absolute levels of the given constituent in the smoke, and
also between levels which have been normalized to a constant nicotine delivery.
For the Code 32 variant, smoke generated on-site shows little difference in
composition from that generated analytically. Such is not the case for the
other two variants. Code 13 smoke generated by the Maddox-ORNL contains
substantially more neophytadiene than "analytical" smoke. The Code 27
°on-site® smoke exhibits a radically different chemical profile than the analyt-
ical smoke. The "on-site" smoke appears to contain substantially lower levels
of the free fatty acids, and significantly higher levels of neophytadiene,
phenol, and the cresols. As suggested by, the wide differences in the nicotine
deliveries, the Code 27 cigarettes used at BNW on this visit may not be truly
representative. However, the data does indicate that significant changes in
smoke chemistry of the Code 27 may occur under exposure conditions at BNW.
Confirmation of this will be necessary on future site visits.

TABLE I
Total Particulate Matter (TPM) and Nicotine Delivery
of Cigarettes Smoked on Selected Maddox-ORNL Smoking
Machines in Service at BNW on February 24, 1977
Cigarette
Code Platfornz
Desjqnati on
Sa
r~1 l
e No. TPM
mq/ci c~ Nicotine
mg/ci g Nicotine:TPM
Rati o
_ _
_ __
32 I 1 36.6 2.22 .0607
I 2 39.4 2.35 .0596
I 3 39.0 2.66 .0682
I 4 32.8 2.24 .0683
G 5 45.1 2.22 .0492
G 6 45.7 2.35 .0514
G 7 38.5 2.55 .0662
G 8 38.8 2.53 .0652
Average 39.5 ± 4.2 2.39 ± 0.16 .0611 ± 0.0074
27 I 1 23.8 1.59 .0668
I 2 21.8 1.47 .0674
I 3 26.8 1.61 .0601
I 4 19.6 1.28 .0653
H 5 19.6 1.24 .0633
H 6 27.0 1.51 .0559
H 7 24.7 1.55 .0628
H 8 24.6 1.53 .0622
Average 23.5 ± 2.9 1.47 ± 0.14 .0630 ± 0.0038
13 1 1 29.6 0.23 .0078
1 2 29.9 0.23 .0077
1 3 31.5 0.25 .0079
1 4' 29.0 0.22 .0076
G 5 31.0 0.22 .0071
G 6 27.5 0.22 .0080
G 7 33.3 0.23 .0069
G 8 28.9 0.22 .0076
Average 30.1 ± 1.8 0.23 ± 0.01 .0076 t.0004

TABLE II
Comparison of Cigarette Deliveries
Input to Maddox-ORNL SmoLi ng Machi nes at BNW vs Analyti cal Smoki ng Machi ne
Maddox-ORNL Analytical*
Cigarett
Code e
# Puffs TPM
mg/cig Nicotine
mg/cig
# Puffs TPM
mg/cig Nicotine
mg/cig
32 10.3 ± 0.5 39.5 ± 4.2 2.39 ± 0.16 9.8 ± 0.5 34.1 ± 2.1 1.92 ± 0.13
2 7 7.6 ± 0.5 23.5 ± 2.9 1.47 ± 0.14 8.0 ± 0.2 17.7 ± 1.2 0.89 ± 0.06
13 9.1 ± 0.6 30.1 ± 1.8 0.23 ± 0.01 9.6 ± 0.5 27.9 ± 1.6 0.20 ± 0.02
*Average results for 8 cigarettes per code smoked on the Phipps and Bird smoking machine
at ORNL at 1 puff/minute, 1 cigarette per pad.

TABLE III
TPM, Nicotine, and Tar Deliveries of Cigarettes Sampled Monthly
from BNW Rat Inhalation Bioassay Assayed Under Analytical Conditions at ORNLa
DATE
amponent Cigare~te
Code
May ' 76
June
July
August
September
October
November
Dec. '76
Jan. '77
Feb. '77
PM
mg/cig
32
33.1+0.8
32.0±0.9
29.3±0.8
31.7-+0.9
31.7±1.8
31.9±2.7
32.9=0.7
32.7±1.5
33.5_1.8
27 1'5.4_0.2 ll.l±1.i 17.5+0.1 15.3±0.4 15.3±0.4 10.7±1.6 16.1±1.4 15.2±1.7 16.9±1.9 18.0±1
.2
13 28.4±0.2 21.5±0.6 27.5±1.3 25.7±0.9 25.7±0.9 24.5±5.8 33.7±8.3 27.7~~0.9 28.9±0.8 28.4±
0.1
icotine
mg/cig
32
1.84±0.09
1.79+0.04
1.66±0.10
1.81T0.06
1.77±0.03
1.66±0.17
1.67±0.02
1.58±0.13
1.93±0.10
27 0.85±0.01 0.93±0.06 0.98±0.01 0.75±0.02 0.90±0.01 0.624--0.02 0.86±0.04 0.74±0.04 0.71±0
.04 1.04±0.01
13 0.1910.01 0.13+-0.01 0.17±0.01 0.15±0.01 0.19+-0.01 0.16±0.01 0.19±0.01 0.18±0.01 0.19±0.0
1 0.18±0.01
c
ar
m91ci9
32
27.9+0.7
26.3±0.8
24.6±0.8
26.2±0.08
26.3±1.6
26.7±2.8
27.6_0.5
27.7±1.1
27.6±1.6
27 11.6±0.2 7.3±1.2 12.8±0.4 11.7±0.2 10.6±1.8 8.3±1.4 12.3±1.0 11.9+1.2 13.9+1.9 13.2+0.9
13 24.7=0.1 18.9±0.5 23.3±0.7 22.3±0.7 21.5±5.6 30.0±2.2 22.9±2.2 24.1+0.7 25.0±0.08 24.7±0
.1
a 8 cigarettes per code for Codes 13 and 27, 16 cigarettes for Code 32.
b Code "32" is used to represent all of the SEV IV Variants (04,14,29,32).
C Tar = TPM less water and nicotine.
z694C4se
_: . ~ .~. ..
.,
~.,
